Pinned Tweet
Anyone still here?! Check out our latest preprint, unraveling more of the complexities of Tregs and iron metabolism: Tissues Guide Dependence of Treg on the Transferrin Receptor biorxiv.org/content/10.64898…
Cheers!
My department is hiring a new faculty member. It is a wonderful research environment and I highly recommend!!
We’re hiring! We seek candidates at the forefront of drug development, mechanisms of drug action, and novel pharmacological approaches who apply these tools to fundamental, exciting questions in biology. Apply today: apply.interfolio.com/193470
Kelsey Voss retweeted
🎉 Congrats to Desai Lab grad student John Duncan on receiving NIH F31 funding to study "TRPM7-V-ATPase coupling in endolysosomal acidification"! His work explores how macrophages keep their pathogen-fighting compartments acidic. 🧫🔬 #NIHFunded #PharmStudent #ImmunologyResearch
Kelsey Voss retweeted
Today, in #preprinthub2 Michelle @UVAimmunology
will present a #preprint on how gut #microbiome changes over the course of multiple sclerosis differentially influence #autoimmune #neuroinflammation @RISEHealthPT @CIBER_ISCIII 🥦🧩🦠
biorxiv.org/content/10.64898…
Kelsey Voss retweeted
Today, in #preprinthub2 Chloe and Meredith @UVAimmunology will present a #preprint from the Martin Vaeth lab @Uni_WUE on how the glucose transporter GLUT3 controls #Treg function
biorxiv.org/content/10.64898…
Kelsey Voss retweeted
I currently have three papers in review at "high impact" journals.
One of them has been sitting there for two years. In that time my daughter was born and learned how to walk, but apparently publishing a PDF was still not possible for me. For another one, after four months in review the editor told me they cannot find a second reviewer and asked me to suggest more reviewers. A third one sent me a message in 2026 saying the PDF I uploaded was larger than 10 MB and that I should please reupload everything to make the file smaller.
All of this just to eventually pay between 7,000 and 12,000 USD per paper so someone can officially approve that the science we do is "legitimate". Reminder: not a single reviewer will be compensated here.
I still don't understand how we as scientists can collectively be so smart when doing science and still tolerate a system like this when it comes to sharing our findings. We should move to preprints plus open review, whether human or AI, asap. So frustrated about it.
I'd suggest sharing your work on bioRxiv or medRxiv, reading and reviewing preprints when you can, and highlighting good research, especially if it is still a preprint. Try platforms like ResearchHub (that pay for peer review) and experiment with AI based reviewers for faster feedback.
Instead I read this as a proposed "revolutionary" measure:
Kelsey Voss retweeted
Join the Iron Community in Dublin, Ireland, from 18 to 20 June for the European Iron Club 2026!
EIC will showcase the latest breakthroughs in iron metabolism & feature cutting-edge presentations, & unique networking opportunities!
Register at eic-2026.com
Kelsey Voss retweeted
Check out our pre-print!! cool new story from our lab on candida infection and diabetes
Hyperglycemia promotes maladaptive Dectin-1 signaling and impairs skin antifungal host defense. biorxiv.org/content/10.64898…
Kelsey Voss retweeted
McGill University (@mcgillu) has many open faculty and postdoctoral positions with generous funding packages, thanks to Impact+ grants, which are investing $2 billion to attract global talent to Canada 🇨🇦🇨🇦🇨🇦.
Associate/Full Professor: $8 million startup package
Assistant Professor: $600K startup package
Postdoc: $70K (starting salary)
If you are interested and work in the space of AI/ML/NLP/LLMs, please reach out to me.
#AI #NLProc #ML
Check out this exciting collaboration with @IG_lab now available as a preprint-
Development and application of nbLIBRA-seq for high-throughput discovery of antigen-specific nanobodies biorxiv.org/content/10.64898…
So fun to take this risk and watch it succeed. 🍾
Tregs finally getting the recognition they deserve!! Congratulations to the winners 🤩
“I believe this will encourage immunologists and physicians to apply T regulatory cells to treat various immunological diseases.”
This year’s Nobel Prize laureate, Shimon Sakaguchi, discovered a new class of T cells that protect the body from autoimmune diseases.
Just after the prize announcement we spoke to him about the fundamental research question that kept him dedicated to the field long after many others gave up.
Listen to our interview with the happy and surprised laureate:
#NobelPrize
Kelsey Voss retweeted
BREAKING NEWS
The 2025 #NobelPrize in Physiology or Medicine has been awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi “for their discoveries concerning peripheral immune tolerance.”
I was just talking about this yesterday.
Kelsey Voss retweeted
🚨 Big news in autoimmune research!
The Lupus Research Alliance and our partners Breakthrough T1D and the National MS Society are excited to announce the Common Mechanisms in Autoimmunity Insight Award — a bold new grant program designed to unlock the understanding of autoimmune diseases and accelerate potential therapies.
Seven recipients were chosen for their innovative proposals to investigate shared mechanisms underlying type 1 diabetes, lupus, and/or multiple sclerosis — and beyond.
This initiative is about fueling understanding, bridging gaps, and fast-tracking innovation across autoimmune conditions.
Together, we’re moving closer to smarter, more targeted treatments.
🔗 Learn more about the how these projects are accelerating progress: bit.ly/LRACMA-25
#AutoimmuneResearch #Lupus #MS #Type1Diabetes #Lupus #LupusResearch
Breakthrough T1D, Lupus Research Alliance, and National Multiple Sclerosis Society Award Recipients of First Common Mechanisms of Autoimmunity Insight Award - Lupus Research Alliance lupusresearch.org/breakthrou…
Excited to be among the recipients of this autoimmunity Insight Award. A lot of exciting projects here and highlights a bright start for the Voss lab 💪 decodingautoimmunity.org/
So interesting and so many unexpected findings here. NK cells, really? 🧐🤷🏻♀️
Can you rejuvenate an old brain by giving it young immune cells? 🧠
My lab @calico put it to the test. In our new study, we replaced the brain's immune cells in old mice with young ones.
The result? The old brain environment forced the young cells to age RAPIDLY. A 🧵👇























